Effects of Meditation Training and Non-Native Language Training on Cognition in Older Adults: A Secondary Analysis of a Randomized Clinical Trial.


Journal

JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235

Informations de publication

Date de publication:
03 Jul 2023
Historique:
medline: 17 7 2023
pubmed: 14 7 2023
entrez: 14 7 2023
Statut: epublish

Résumé

Nonpharmacological interventions are a potential strategy to maintain or promote cognitive functioning in older adults. To investigate the effects of 18 months' meditation training and 18 months' non-native language training on cognition in older adults. This study was a secondary analysis of the Age-Well trial, an 18-month, observer-masked, randomized clinical trial with 3 parallel arms. Eligible participants were community-dwelling adults aged 65 years and older residing in Caen, France. Participants were enrolled from November 24, 2016, to March 5, 2018, and randomly assigned (1:1:1) to meditation training, non-native language (English) training, or no intervention arms. Final follow-up was completed on February 6, 2020. Data were analyzed between December 2021 and November 2022. The 18-month meditation and non-native language training interventions were structurally equivalent and included 2-hour weekly group sessions, daily home practice of 20 minutes or longer, and 1 day of more intensive home practice. The no intervention group was instructed not to change their habits and to continue living as usual. Cognition (a prespecified secondary outcome of the Age-Well trial) was assessed preintervention and postintervention via the Preclinical Alzheimer Cognitive Composite 5 (PACC5), and composites assessing episodic memory, executive function, and attention. Among 137 randomized participants, 2 were excluded for not meeting eligibility criteria, leaving 135 (mean [SD] age, 69.3 [3.8] years; 83 female [61%]) eligible for analysis. One participant among the remaining 135 did not complete the trial. In adjusted mixed effects models, no interaction effects were observed between visit and group for PACC5 (F2,131.39 = 2.58; P = .08), episodic memory (F2,131.60 = 2.34; P = .10), executive function (F2,131.26 = 0.89; P = .41), or attention (F2,131.20 = 0.34; P = .79). Results remained substantively unchanged across sensitivity and exploratory analyses. In this secondary analysis of an 18-month randomized trial, meditation and non-native language training did not confer salutary cognitive effects. Although further analyses are needed to explore the effects of these interventions on other relevant outcomes related to aging and well-being, these findings did not support the use of these interventions for enhancing cognition in cognitively healthy older adults. ClinicalTrials.gov Identifier: NCT02977819.

Identifiants

pubmed: 37450303
pii: 2807261
doi: 10.1001/jamanetworkopen.2023.17848
pmc: PMC10349342
doi:

Banques de données

ClinicalTrials.gov
['NCT02977819']

Types de publication

Randomized Controlled Trial Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2317848

Investigateurs

Florence Allais (F)
Claire André (C)
Eider Arenaza-Urquijo (E)
Julien Asselineau (J)
Sebastian Baez Lugo (S)
Martine Batchelor (M)
Axel Beaugonin (A)
Alexandre Bejanin (A)
Maelle Botton (M)
Pierre Champetier (P)
Anne Chocat (A)
Robin De Flores (R)
Vincent De La Sayette (V)
Pascal Delamilleure (P)
Stéphanie Egret (S)
Hélene Espérou (H)
Francesca Felisatti (F)
Eglantine Ferrand-Devouges (E)
Antoine Garnier-Groussard (A)
Francis Gheysen (F)
Marc Heidmann (M)
Anne Hendy (A)
Thien Huong Tran (T)
Agathe Joret Philippe (A)
Elizabeth Kuhn (E)
Brigitte Landeau (B)
Gwendoline Le Du (G)
Valérie Lefranc (V)
Florence Mezenge (F)
Inés Moulinet (I)
Valentin Ourry (V)
Cassandre Palix (C)
Anne Quillard (A)
Géraldine Rauchs (G)
Stéphane Rehel (S)
Corrine Schwimmer (C)
Siya Sherif (S)
Clémence Tomadesso (C)
Edelweiss Touron (E)
Matthieu Vanhoutte (M)

Références

Gen Psychiatr. 2019 Aug 8;32(4):e100069
pubmed: 31552383
Br J Clin Psychol. 2014 Mar;53(1):1-5
pubmed: 24588759
Front Aging Neurosci. 2021 Nov 12;13:706672
pubmed: 34867264
Neuropsychol Rev. 2022 Sep;32(3):677-702
pubmed: 34350544
J Manag Care Spec Pharm. 2021 Nov;27(11):1613-1617
pubmed: 34714106
Alzheimers Dement (Amst). 2020 May 15;12(1):e12017
pubmed: 32432155
Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2023 Mar;30(2):150-171
pubmed: 34694201
Alzheimers Dement. 2020 Mar;16(3):552-560
pubmed: 31759879
Aging Ment Health. 2022 Sep;26(9):1699-1709
pubmed: 34587844
Alzheimers Dement (N Y). 2017 Nov 10;3(4):668-677
pubmed: 29264389
Psychol Aging. 2020 Mar;35(2):212-219
pubmed: 32011156
Front Neurosci. 2019 May 15;13:423
pubmed: 31156360
Psychol Res. 2023 Feb;87(1):294-307
pubmed: 35226153
Front Hum Neurosci. 2012 Oct 25;6:296
pubmed: 23112770
J Behav Ther Exp Psychiatry. 2000 Jun;31(2):73-86
pubmed: 11132119
Alzheimers Dement (N Y). 2018 Dec 14;4:714-723
pubmed: 30581977
Mindfulness (N Y). 2014;5:453-459
pubmed: 25067961
JAMA Neurol. 2022 Nov 1;79(11):1165-1174
pubmed: 36215061
Ageing Res Rev. 2021 Dec;72:101495
pubmed: 34718153
Neurosci Biobehav Rev. 2013 Dec;37(10 Pt 2):2689-98
pubmed: 24051310
Alzheimers Res Ther. 2022 Sep 6;14(1):125
pubmed: 36068621
Nat Rev Neurol. 2019 Feb;15(2):73-88
pubmed: 30610216
J Alzheimers Dis. 2021;83(1):127-141
pubmed: 34275899
JAMA. 2022 Dec 13;328(22):2218-2229
pubmed: 36511926

Auteurs

Harriet Demnitz-King (H)

Division of Psychiatry, University College London, London, United Kingdom, W1T 7NF.

Florence Requier (F)

GIGA-CRC In Vivo Imaging, University of Liège, Liège, Belgium.
Psychology and Cognitive Neuroscience Unit, University of Liège, Liège, Belgium.

Tim Whitfield (T)

Division of Psychiatry, University College London, London, United Kingdom, W1T 7NF.

Marco Schlosser (M)

Division of Psychiatry, University College London, London, United Kingdom, W1T 7NF.
Department of Psychology, Faculty of Psychology and Educational Sciences, University of Geneva, Geneva, Switzerland.

Julie Gonneaud (J)

Normandie Univ, UNICAEN, INSERM, U1237, Physiopathology and Imaging of Neurological Disorders (PhIND), Institut Blood and Brain @ Caen-Normandie, Cyceron, France.

Caitlin Ware (C)

Normandie Univ, UNICAEN, INSERM, U1237, Physiopathology and Imaging of Neurological Disorders (PhIND), Institut Blood and Brain @ Caen-Normandie, Cyceron, France.
Centre de recherches psychanalyse, médecine et société (CPRMS), Université de Paris, Paris, France.

Thorsten Barnhofer (T)

School of Psychology, University of Surrey, Guildford, United Kingdom.

Nina Coll-Padros (N)

Alzheimer's Disease and Other Cognitive Disorders Unit, Hospital Clinic, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.

Sophie Dautricourt (S)

Normandie Univ, UNICAEN, INSERM, U1237, Physiopathology and Imaging of Neurological Disorders (PhIND), Institut Blood and Brain @ Caen-Normandie, Cyceron, France.
Neurology Department, University Hospital, Caen, France.

Marion Delarue (M)

Normandie Univ, UNICAEN, INSERM, U1237, Physiopathology and Imaging of Neurological Disorders (PhIND), Institut Blood and Brain @ Caen-Normandie, Cyceron, France.

Olga M Klimecki (OM)

Clinical Psychology and Behavioral Neuroscience, Faculty of Psychology, Technische Universität Dresden, Dresden, Germany.

Léo Paly (L)

Normandie Univ, UNICAEN, INSERM, U1237, Physiopathology and Imaging of Neurological Disorders (PhIND), Institut Blood and Brain @ Caen-Normandie, Cyceron, France.

Eric Salmon (E)

GIGA-CRC In Vivo Imaging, University of Liège, Liège, Belgium.
Psychology and Cognitive Neuroscience Unit, University of Liège, Liège, Belgium.

Ann-Katrin Schild (AK)

Department of Psychiatry, Medical Faculty, University of Cologne, Cologne, Germany.

Miranka Wirth (M)

German Center for Neurodegenerative Diseases (DZNE), Dresden, Germany.

Eric Frison (E)

Bordeaux Population Health Center, University of Bordeaux, INSERM, EUCLID/F-CRIN Clinical Trials Platform, CHU Bordeaux, Bordeaux, France.
Service d'information médicale, CHU Bordeaux, Bordeaux, France.

Antoine Lutz (A)

Eduwell team, Lyon Neuroscience Research Center INSERM U1028, CNRS UMR5292, Lyon 1 University, Bron, Lyon, France.

Gaël Chételat (G)

Normandie Univ, UNICAEN, INSERM, U1237, Physiopathology and Imaging of Neurological Disorders (PhIND), Institut Blood and Brain @ Caen-Normandie, Cyceron, France.

Fabienne Collette (F)

GIGA-CRC In Vivo Imaging, University of Liège, Liège, Belgium.
Psychology and Cognitive Neuroscience Unit, University of Liège, Liège, Belgium.

Natalie L Marchant (NL)

Division of Psychiatry, University College London, London, United Kingdom, W1T 7NF.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH